Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors

Outcomes of Trabeculectomy With MMC Clinical Trial

Official title:

Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03293251
• Other study ID #: 1111
• Status: Active, not recruiting
• Phase: N/A
• First received: September 20, 2017
• Last updated: September 24, 2017
• Start date: August 1, 2017
• Est. completion date: December 29, 2018

Study information

• Verified date: September 2017
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

1. determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not.

2. Success rates of trabeculectomy with MMC in Queen Elizabeth hospital.

3. recurrence rate of uveitis after glaucoma surgery

Description:

1. determine different success rates of trabeculectomy with MMC undergone in QE hospital, UK.

2. determine different complications and effect of cataract surgery on the outcome of glaucoma surgery

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 70
• Est. completion date: December 29, 2018
• Est. primary completion date: October 29, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Fesh trabeculectomy surgeries

Exclusion Criteria:

• recurrent surgeries

Related Conditions & MeSH terms

• Glaucoma
• Outcomes of Trabeculectomy With MMC

Intervention

Procedure:
• Trabeculectomy with MMC
glaucoma surgeries

Locations

Country	Name	City	State
Egypt	Maha Said	Egypt	Assiut

Sponsors (2)

Lead Sponsor	Collaborator
Assiut University	Queen Elizabeth Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rates	IOP less 21 mmHg	5 year period